Charles M. Epstein, MD - US grants
Affiliations: | Emory University | Emory University, Atlanta, GA |
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the NIH Research Portfolio Online Reporting Tools and the NSF Award Database.The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please sign in and mark grants as correct or incorrect matches.
High-probability grants
According to our matching algorithm, Charles M. Epstein is the likely recipient of the following grants.Years | Recipients | Code | Title / Keywords | Matching score |
---|---|---|---|---|
2001 — 2004 | Epstein, Charles M [⬀] | R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Magnetic Stimulation For Parkinson Disease @ Emory University The major aim of this study is to carry out a sequential Phase I trial of prefrontal transcranial disease (PD) and severe depression. Depression complicates PD in up to 50 percent of cases, leading to further deterioration of motor performance and quality of life; but antidepressant medication fails or produces intolerable side effects in 25-30 percent of patients. Case reports and uncontrolled trials suggest that ect is effective in ameliorating simultaneously the mood and motor symptoms of PD. Only a few small studies of ECT in PD have been prospective or randomized, the assessment protocols have been limited, and the results have been variable. TMS is a new, promising, alternative treatment for refractory depression, which appears to be easier and safer that ETC. Requiring no hospitalization, anesthesia, or recovery time, TMS is now being investigated as an alternative therapy for mood disorders. TMS has not been studied in depressed patients with PD or in other serious central nervous system diseases. This study extends our past and present research in PD, depression, ECT, and TMS. We will comprehensively evaluate the effects of left prefrontal TMS on mood, motor, and neuropsychological function together with quality of life indices in depressed PD patients. All patients will initially receive treatment with TMS. Those who fail to benefit will proceed to ETC. Comprehensive evaluation will be continued for another eight weeks in both the TMS-only and ECT groups. The key issues addressed by these studies include (1) the potential benefit of TMS on mood and movement in depressed PD patient, and (2) the tightness of the association between mood and motor function after TMS and ETC. Overall, these studies will provide important preliminary data on the relationships among mood, cognitive and motor function in PD, and their influence on quality of life. The results will help in directing future applications of TMS as an alternative therapy for brain disorders, and will further elucidate the relative benefits of both TMS and ECT in depressed PD patients. A positive effects from TMS should be an impetus towards randomized, placebo-controlled trials. |
1 |
2004 — 2006 | Epstein, Charles J [⬀] Epstein, Charles J [⬀] | M01Activity Code Description: An award made to an institution solely for the support of a General Clinical Research Center where scientists conduct studies on a wide range of human diseases using the full spectrum of the biomedical sciences. Costs underwritten by these grants include those for renovation, for operational expenses such as staff salaries, equipment, and supplies, and for hospitalization. A General Clinical Research Center is a discrete unit of research beds separated from the general care wards. |
Transcranial Magnetic Stimulation For Depression in Parkinson's Disease @ Emory University transcranial magnetic stimulation; nervous system disorder therapy; clinical depression; Parkinson's disease; gait; neuropsychology; muscle rigidity; tremor; abnormal involuntary movement; patient oriented research; clinical research; human subject; |
0.915 |
2006 — 2007 | Epstein, Charles J [⬀] Epstein, Charles J [⬀] | M01Activity Code Description: An award made to an institution solely for the support of a General Clinical Research Center where scientists conduct studies on a wide range of human diseases using the full spectrum of the biomedical sciences. Costs underwritten by these grants include those for renovation, for operational expenses such as staff salaries, equipment, and supplies, and for hospitalization. A General Clinical Research Center is a discrete unit of research beds separated from the general care wards. |
Accelerated Rtms Treatment For Parkinson's Disease Comorbid With Depression @ Emory University |
0.915 |
2011 — 2015 | Sathian, Krishnankutty [⬀] Epstein, Charles (co-PI) [⬀] |
N/AActivity Code Description: No activity code was retrieved: click on the grant title for more information |
@ Emory University Metaphors are not just ossified expressions in grammar books. Rather, they are living, evolving expressions that pepper our language far more heavily than one might think. Many expressions that we take for granted are actually metaphorical, that is, they represent one concept by referring to another. For instance, the sentence 'He was feeling down' actually involves metaphorical usage of the spatial word 'down.' Given their ubiquity, processes in the brain that mediate comprehension and production of metaphors are critically important to human language. Dr. Krishnankutty Sathian of Emory University and his colleagues are carrying out a project to determine how metaphors are processed by the brain. It turns out that metaphors very often represent a somewhat abstract concept by implicitly invoking similarity to a more concrete concept that is grounded in our sensory experiences. For example, in the sentence, 'She had a rough day,' the word 'rough' connotes something unpleasant, similar to the way a rough surface feels unpleasant. Much research has already established that various sensory domains, such as color, shape, texture and spatial location, are each processed in relatively distinct sectors of the brain (specifically, within parts known collectively as "sensory cortex"). Dr. Sathian's project is testing whether or not understanding metaphors involves activation of those particular sensory cortical regions (e.g. the region specialized for processing texture in the case of metaphorical usage of 'rough'). In order to do this, brain scans using functional magnetic resonance imaging (fMRI) are being carried out while healthy volunteers listen to sentences containing metaphors. The brain responses to metaphors are being contrasted with responses during presentation of sentences of similar difficulty but lacking metaphors. How different brain regions interact is also being examined using measures of neural connectivity. Even if the predicted sensory cortical activity is found, it does not mean that the activity is actually necessary for metaphor comprehension. To test the necessity of cortical activity, another technique known as 'transcranial magnetic' stimulation (TMS) is being used. Tiny magnetic pulses are applied to specific brain regions to transiently disrupt their function. If TMS over particular sensory cortical regions affects understanding of the corresponding metaphors, then those sensory regions are truly necessary for understanding metaphors. |
0.915 |